EP Patent

EP0580662B1 — Catalase, its production and use

Assigned to Novozymes AS · Expires 1998-06-10 · 28y expired

What this patent protects

PCT No. PCT/DK92/00098 Sec. 371 Date Sep. 15, 1993 Sec. 102(e) Date Sep. 15, 1993 PCT Filed Mar. 27, 1992 PCT Pub. No. WO92/17571 PCT Pub. Date Oct. 15, 1992The present invention relates to catalases obtained from a strain of Scytalidium thermophilum or Humicola insolens which re…

USPTO Abstract

PCT No. PCT/DK92/00098 Sec. 371 Date Sep. 15, 1993 Sec. 102(e) Date Sep. 15, 1993 PCT Filed Mar. 27, 1992 PCT Pub. No. WO92/17571 PCT Pub. Date Oct. 15, 1992The present invention relates to catalases obtained from a strain of Scytalidium thermophilum or Humicola insolens which retains at least 75% residual activity after 20 minutes at 70 DEG C. and a pH in the range of 9.0-10.5 in the presence of 40 mM polyvinyl pyrrolidone and methods for producing and using same.

Drugs covered by this patent

Patent Metadata

Patent number
EP0580662B1
Jurisdiction
EP
Classification
—
Expires
1998-06-10
Drug substance claim
No
Drug product claim
No
Assignee
Novozymes AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.